Impact of pre-treatment C-reactive protein level and skeletal muscle mass on outcomes after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer: a supplementary analysis of the Japan Clinical Oncology Group study JCOG0403

This study aimed to evaluate the impact of pretreatment C-reactive protein (CRP) and skeletal muscle mass (SMM) on outcomes after stereotactic body radiotherapy (SBRT) for T1N0M0 non-small cell lung cancer (NSCLC) as a supplementary analysis of JCOG0403. Patients were divided into high and low CRP g...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuo, Yukinori, Nagata, Yasushi, Wakabayashi, Masashi, Ishikura, Satoshi, Onishi, Hiroshi, Kokubo, Masaki, Karasawa, Katsuyuki, Shioyama, Yoshiyuki, Onimaru, Rikiya, Hiraoka, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Oncology/Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438483/
https://www.ncbi.nlm.nih.gov/pubmed/34350956
http://dx.doi.org/10.1093/jrr/rrab065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438483/
https://www.ncbi.nlm.nih.gov/pubmed/34350956
http://dx.doi.org/10.1093/jrr/rrab065

Ejemplares similares